128 related articles for article (PubMed ID: 34256503)
1. Can LENT Prognostic score (LDH, ECOG performance score, blood neutrophil/lymphocyte ratio, tumor type) change the clinical approach in malignant pleural effusion?
Gayaf M; Anar C; Canbaz M; Doğan Bİ; Erbaycu AE; Güldaval F
Tuberk Toraks; 2021 Jun; 69(2):133-143. PubMed ID: 34256503
[TBL] [Abstract][Full Text] [Related]
2. Predicting survival in malignant pleural effusion: development and validation of the LENT prognostic score.
Clive AO; Kahan BC; Hooper CE; Bhatnagar R; Morley AJ; Zahan-Evans N; Bintcliffe OJ; Boshuizen RC; Fysh ET; Tobin CL; Medford AR; Harvey JE; van den Heuvel MM; Lee YC; Maskell NA
Thorax; 2014 Dec; 69(12):1098-104. PubMed ID: 25100651
[TBL] [Abstract][Full Text] [Related]
3. Prognostic impact of a new score using neutrophil-to-lymphocyte ratios in the serum and malignant pleural effusion in lung cancer patients.
Lee YS; Nam HS; Lim JH; Kim JS; Moon Y; Cho JH; Ryu JS; Kwak SM; Lee HL
BMC Cancer; 2017 Aug; 17(1):557. PubMed ID: 28830378
[TBL] [Abstract][Full Text] [Related]
4. Eosinophilic pleural effusion due to lung cancer has a better prognosis than non-eosinophilic malignant pleural effusion.
Takeuchi E; Okano Y; Machida H; Atagi K; Kondou Y; Kadota N; Hatakeyama N; Naruse K; Shinohara T
Cancer Immunol Immunother; 2022 Feb; 71(2):365-372. PubMed ID: 34170380
[TBL] [Abstract][Full Text] [Related]
5. The clinical utility of the LENT score in patients with malignant pleural mesothelioma.
Söyler Y; Kavurgacı S; Gürel Akan E; Yılmaz Ü
Tuberk Toraks; 2022 Dec; 70(4):341-348. PubMed ID: 36537091
[TBL] [Abstract][Full Text] [Related]
6. An Observational Study Evaluating the Performance of LENT Score in the Selected Population of Malignant Pleural Effusion from Lung Adenocarcinoma in Singapore.
Abisheganaden J; Verma A; Dagaonkar RS; Light RW
Respiration; 2018; 96(4):308-313. PubMed ID: 29945142
[TBL] [Abstract][Full Text] [Related]
7. Prognostic value of a new score using serum alkaline phosphatase and pleural effusion lactate dehydrogenase for patients with malignant pleural effusion.
Shi XY; Yi FS; Wang Z; Qiao X; Zhai K
Thorac Cancer; 2020 Feb; 11(2):320-328. PubMed ID: 31837116
[TBL] [Abstract][Full Text] [Related]
8. Laboratory Discrimination Between Neutrophilic Malignant and Parapneumonic Pleural Effusions.
Lee J; Lee YH; Seo H; Lee H; Kim YK; Yoo SS; Lee SY; Cha SI; Park JY; Kim CH
Am J Med Sci; 2019 Aug; 358(2):115-120. PubMed ID: 31331448
[TBL] [Abstract][Full Text] [Related]
9. Breast and Lung Effusion Survival Score Models: Improving Survival Prediction in Patients With Malignant Pleural Effusion and Metastasis.
Molina S; Martinez-Zayas G; Sainz PV; Leung CH; Li L; Grosu HB; Adachi R; Ost DE
Chest; 2021 Sep; 160(3):1075-1094. PubMed ID: 33852918
[TBL] [Abstract][Full Text] [Related]
10. Neutrophil-to-lymphocyte ratio in malignant pleural fluid: Prognostic significance.
Popowicz N; Cheah HM; Gregory C; Miranda A; Dick IM; Lee YCG; Creaney J
PLoS One; 2021; 16(4):e0250628. PubMed ID: 33901252
[TBL] [Abstract][Full Text] [Related]
11. Malignant pleural effusion survival prognostication in an Asian population.
Quek JC; Tan QL; Allen JC; Anantham D
Respirology; 2020 Dec; 25(12):1283-1291. PubMed ID: 32390227
[TBL] [Abstract][Full Text] [Related]
12. Prediction modeling using routine clinical parameters to stratify survival in malignant pleural mesothelioma patients complicated with malignant pleural effusion.
Zhang S; Zhang Y; Feng W; Shi Z; Shi H; Zhang Y
Thorac Cancer; 2021 Dec; 12(24):3304-3309. PubMed ID: 34704370
[TBL] [Abstract][Full Text] [Related]
13. Prognostic Factors of Malignant Pleural Effusion among Palliative Care Outpatients: A Retrospective Study.
Jeba J; Cherian RM; Thangakunam B; George R; Visalakshi J
Indian J Palliat Care; 2018; 24(2):184-188. PubMed ID: 29736123
[TBL] [Abstract][Full Text] [Related]
14. The role of LENT and PROMISE scores in predicting survival in malignant pleural effusion.
Ermin S; Özdogan Y; Batum Ö; Yilmaz U
Lung India; 2022; 39(4):325-330. PubMed ID: 35848663
[TBL] [Abstract][Full Text] [Related]
15. Development and validation of the CAIL prognostic score in non-small cell lung cancer patients with malignant pleural effusion.
Li T; Tian P; Huang Q; Zeng H; Wei Q; Li Y
Clin Respir J; 2023 Nov; 17(11):1158-1168. PubMed ID: 37723659
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of prognostication scores and proposal for refinement in malignant pleural effusion in Asians.
Wong C; Wing-Cheuk Wong R; Kit-Ying So L; Yin-Chun Yam L
Respir Med; 2021; 189():106650. PubMed ID: 34688123
[TBL] [Abstract][Full Text] [Related]
17. Important prognostic factors for survival in patients with malignant pleural effusion.
Zamboni MM; da Silva CT; Baretta R; Cunha ET; Cardoso GP
BMC Pulm Med; 2015 Mar; 15():29. PubMed ID: 25887349
[TBL] [Abstract][Full Text] [Related]
18. Survival in Patients With Malignant Pleural Effusions Who Developed Pleural Infection: A Retrospective Case Review From Six UK Centers.
Bibby AC; Clive AO; Slade GC; Morley AJ; Fallon J; Psallidas I; Pepperell JCT; Slade MG; Stanton AE; Rahman NM; Maskell NA
Chest; 2015 Jul; 148(1):235-241. PubMed ID: 25429399
[TBL] [Abstract][Full Text] [Related]
19. Validating LENT score in malignant pleural effusion.
Alawneh A; Farsakh FA; Smadi M; Samrah S
Future Sci OA; 2024; 10(1):FSO958. PubMed ID: 38817378
[No Abstract] [Full Text] [Related]
20. Does the LENT score risk-stratify patients with malignant pleural mesothelioma? An observational study.
Chollet B; Guinde J; Laroumagne S; Dutau H; Astoul P
Thorac Cancer; 2021 Jun; 12(11):1752-1756. PubMed ID: 33949775
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
